Therefore, targeting microglial NADPH oxidase NOX2 has been suggested as a promising strategy to prevent or reduce oxidative stress-induced damage of brain tissue in neurological diseases, which are accompanied by neuroinflammation [2, 45, 46]. The gene discussed is FMO5; the disease is nervous system disorder.